PubMed ID,Title,Publication Date,Authors,Company Authors,Company Affiliations
40152799,Economic impact of sotagliflozin among patients with heart failure and type 2 diabetes: Budget impact analysis from the US payer perspective.,2025,"Jason Shafrin, Shanshan Wang, Jaehong Kim, Slaven Sikirica",Slaven Sikirica,"Lexicon Pharmaceuticals, Inc., Bridgewater, NJ."
40152795,"Group-based trajectory modeling to identify longitudinal patterns and predictors of adherence among older adults on concomitant triple therapy (oral antidiabetic, renin-angiotensin-system antagonists, statins).",2025,"Sai S Cheruvu, Bilqees Fatima, Susan Abughosh","Sai S Cheruvu, Bilqees Fatima, Susan Abughosh","Pharmaceutical Health Outcomes and Policy, University of Houston, TX.; Pharmaceutical Health Outcomes and Policy, University of Houston, TX.; Pharmaceutical Health Outcomes and Policy, University of Houston, TX."
40152467,Workshop on Noninvasive Glucose Monitoring 2024.,2025,"Jeon Woong Kang, Mark A Arnold, Devin Steenkamp, Mark A Tapsak, Werner MÃ¤ntele, Yoonho Khang, Miyeon Jue, Peter T C So","Mark A Tapsak, Yoonho Khang, Miyeon Jue","GlucoTrack Inc., Rutherford, NJ, USA.; HME Square Inc., Daejeon, Republic of Korea.; Apollon Inc., Seoul, Republic of Korea."
